Combining SKY92 gene expression profiling and FISH (according to R2‐ISS) defines ultra‐high‐risk Multiple Myeloma

Xiang Zhou; Annika Hofmann; Benedict Engel; Cornelia Vogt; Silvia Nerreter; Yoko Tamamushi; Fabian Schmitt; Maria Leberzammer; Emilia Stanojkovska; Marietta Truger; Xianghui Xiao; Christine Riedhammer; Maximilian Steinhardt; Mara John; Julia Mersi; Seungbin Han; Umair Munawar; Johannes M. Waldschmidt; Claudia Haferlach; Hermann Einsele; Leo Rasche; K. Martin Kortüm

doi:10.1002/hem3.70078

Ask about this paper

Answers are grounded in this paper and cite their sources.

Abstract

= 1). Altogether, we provide the first prospective real-world evidence that the combination SKY92 and FISH (according to R2-ISS) identifies a subset of patients with ultra-HR MM, and WGS complements SKY92 and FISH in MM risk stratification.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Zhou et al. (2025) studied this question.

synapsesocial.com/papers/6a03452fc8c4199b329e4549 https://doi.org/10.1002/hem3.70078

View Full Paper

Ask AI

Bookmark

Share

Combining SKY92 gene expression profiling and FISH (according to R2‐ISS) defines ultra‐high‐risk Multiple Myeloma

Ask about this paper

Abstract

Discussion

Cite This Study

Combining SKY92 gene expression profiling and FISH (according to R2‐ISS) defines ultra‐high‐risk Multiple Myeloma

Ask about this paper

Abstract

Discussion

Cite This Study

Keep reading

Keep reading